Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months.

Wolkerstorfer A, Gooderham MJ, Sebastian M, Rosmarin D, Blauvelt A, Shayesteh Alam M, Zdybski J, Wei S, Kornacki D, Passeron T, Harris JE

Open source

DOI: 10.1111/jdv.70402
Published: 2026 Aug
Container: Journal of the European Academy of Dermatology and Venereology : JEADV
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/jdv.70402,
  title = {Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months.},
  author = {Wolkerstorfer A and Gooderham MJ and Sebastian M and Rosmarin D and Blauvelt A and Shayesteh Alam M and Zdybski J and Wei S and Kornacki D and Passeron T and Harris JE},
  year = {2026},
  journal = {Journal of the European Academy of Dermatology and Venereology : JEADV},
  doi = {10.1111/jdv.70402},
  url = {https://doi.org/10.1111/jdv.70402}
}

RIS

TY  - JOUR
TI  - Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months.
AU  - Wolkerstorfer A
AU  - Gooderham MJ
AU  - Sebastian M
AU  - Rosmarin D
AU  - Blauvelt A
AU  - Shayesteh Alam M
AU  - Zdybski J
AU  - Wei S
AU  - Kornacki D
AU  - Passeron T
AU  - Harris JE
PY  - 2026
JO  - Journal of the European Academy of Dermatology and Venereology : JEADV
DO  - 10.1111/jdv.70402
UR  - https://doi.org/10.1111/jdv.70402
ER  -

APA

A, W., MJ, G., M, S., D, R., A, B., M, S. A., J, Z., S, W., D, K., T, P., & JE, H. (2026). Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months.. Journal of the European Academy of Dermatology and Venereology : JEADV. https://doi.org/10.1111/jdv.70402

Source records

pubmed · retrieved 2026-09-26T21:36:39.678Z